Geron’s Imetelstat Headed To US FDA Advisory Committee For MDS

 
• By Ayisha Sharma
red blood cells
Around 50% Of MDS Patients Experience Thrombocytopenia • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers